Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2022-07-29
2023-08-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of this study is to evaluate the fate and quality of medical follow-up of children born very premature (≤33SA) to homeless mothers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Impact of the Return Home of Premature Newborns Less Than 2 Kilos Morbidity/Mortality
NCT06224764
What is the Future of Vulnerable New-borns
NCT04021654
Hospitalizations in Neonatal Period and Early Discharge of Maternity
NCT05550272
Prematurity at the Limit of Viability
NCT06391476
Implementation of a Tool on Alimentary Empowerment in New-born Baby
NCT03322722
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In recent years, the number of homeless patients who are accomodated by the SAMU social has increased. These patients are in a precarious financial, but also often social and psychological situation. The literature already shows us that precariousness and homelessness are a risk factor for prematurity, but also for the patients themselves, a risk of more frequent recourse to emergency services and late consultation with advanced pathologies.
The aim of this study is to evaluate the fate and quality of medical follow-up of children born very premature (≤33SA) to homeless mothers, by answering the following questions:
* What about the follow-up of their very premature child?
* How does the department organize itself to ensure optimal follow-up for these patients?
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fate and quality of medical follow-up of children born very premature (≤33SA) to homeless mothers
Evaluation of the fate and quality of medical follow-up of children born very premature (≤33SA) to homeless mothers.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Born between January 2019 and December 2021
* At the René Dubos Hospital in Pontoise
* Whose mother did not have a fixed address at the time of discharge.
NB: Mothers who do not read French well will have the study explained to them by the doctor who follows their child during a consultation, or by telephone.
Exclusion Criteria
33 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hôpital NOVO
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr Suzanne BORRHOMEE
Role: PRINCIPAL_INVESTIGATOR
Hôpital NOVO
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Resuscitation and neonatal medicine department - Centre Hospitalier René Dubos
Pontoise, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHRD0522
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.